
DiaMedica Therapeutics DMAC
$ 9.4
0.7%
Quarterly report 2025-Q3
added 11-12-2025
DiaMedica Therapeutics Total Liabilities 2011-2025 | DMAC
Annual Total Liabilities DiaMedica Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 2.08 M | 1.44 M | 1.31 M | 1 M | 627 K | 1.45 M | 1.81 M | 1.52 M | 1.58 M | 365 K |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.08 M | 365 K | 1.32 M |
Total Liabilities of other stocks in the Biotechnology industry
| Issuer | Total Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
1.98 B | - | 2.43 % | $ 254 M | ||
|
AlloVir
ALVR
|
5.24 M | - | 4.14 % | $ 49.1 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
6.45 B | - | - | $ 40.3 B | ||
|
Ascendis Pharma A/S
ASND
|
1.29 B | $ 220.27 | 4.81 % | $ 5 B | ||
|
Can-Fite BioPharma Ltd.
CANF
|
3.45 M | $ 0.28 | -2.28 % | $ 609 M | ||
|
Alterity Therapeutics Limited
ATHE
|
5.89 M | $ 3.3 | -3.51 % | $ 7.94 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
8.16 M | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
6.46 M | - | -18.52 % | $ 27.3 M | ||
|
Aptorum Group Limited
APM
|
4.35 M | $ 1.29 | -3.01 % | $ 7.03 M | ||
|
Biophytis SA
BPTS
|
20.4 M | - | -13.47 % | $ 169 M | ||
|
Институт стволовых клеток человека
ISKJ
|
1.1 B | - | - | - | ||
|
ARCA biopharma
ABIO
|
13.8 M | - | 1052.0 % | $ 415 M | ||
|
Arbutus Biopharma Corporation
ABUS
|
38.4 M | $ 4.75 | 1.61 % | $ 788 M | ||
|
Aclaris Therapeutics
ACRS
|
64.8 M | $ 3.26 | -3.12 % | $ 252 M | ||
|
Acasti Pharma
ACST
|
5.38 M | - | 4.01 % | $ 150 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
243 M | - | -15.15 % | $ 60.3 M | ||
|
Aeglea BioTherapeutics
AGLE
|
90.7 M | - | - | $ 1.01 B | ||
|
Albireo Pharma
ALBO
|
126 M | - | -0.23 % | $ 916 M | ||
|
Alpine Immune Sciences
ALPN
|
107 M | - | - | $ 2.17 B | ||
|
Ampio Pharmaceuticals
AMPE
|
2.38 M | - | -11.43 % | $ 502 K | ||
|
Amphastar Pharmaceuticals
AMPH
|
845 M | $ 25.27 | -2.43 % | $ 1.22 B | ||
|
Applied Molecular Transport
AMTI
|
46.6 M | - | - | $ 10.1 M | ||
|
Anika Therapeutics
ANIK
|
42.3 M | $ 9.57 | 0.84 % | $ 140 M | ||
|
BioNTech SE
BNTX
|
3.12 B | $ 94.73 | -1.32 % | $ 27.2 B | ||
|
Arena Pharmaceuticals
ARNA
|
110 M | - | -6.81 % | $ 3.04 B | ||
|
Athersys
ATHX
|
28.4 M | - | 3.77 % | $ 22.4 M | ||
|
Acer Therapeutics
ACER
|
28.4 M | - | 2.71 % | $ 14 M | ||
|
Avenue Therapeutics
ATXI
|
816 K | - | -52.27 % | $ 4.45 M | ||
|
AVROBIO
AVRO
|
6.35 M | - | 1083.1 % | $ 745 M | ||
|
Axon Enterprise
AXON
|
2.15 B | $ 566.18 | -2.56 % | $ 42.9 B | ||
|
Ayala Pharmaceuticals
AYLA
|
7.43 M | - | - | $ 7.46 M | ||
|
Aytu BioScience
AYTU
|
93.3 M | $ 2.34 | 2.59 % | $ 14.7 M | ||
|
AstraZeneca PLC
AZN
|
63.2 B | $ 89.78 | -0.57 % | $ 96.9 B | ||
|
Acorda Therapeutics
ACOR
|
395 M | - | -24.86 % | $ 820 K | ||
|
Brickell Biotech
BBI
|
6.5 M | - | -5.38 % | $ 6.06 M | ||
|
Burford Capital Limited
BUR
|
1.45 B | $ 9.09 | -0.55 % | $ 1.5 B | ||
|
BeiGene, Ltd.
BGNE
|
2.59 B | - | 0.49 % | $ 251 B | ||
|
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
1.76 B | $ 11.54 | 0.87 % | $ 746 M | ||
|
Biogen
BIIB
|
11.3 B | $ 174.42 | 1.11 % | $ 25.4 B | ||
|
BioVie
BIVI
|
2.55 M | $ 1.42 | -5.96 % | $ 2.1 M | ||
|
Abeona Therapeutics
ABEO
|
49.2 M | $ 5.36 | -2.99 % | $ 115 M | ||
|
Dynavax Technologies Corporation
DVAX
|
389 M | $ 10.85 | -0.14 % | $ 1.41 B | ||
|
ADiTx Therapeutics
ADTX
|
23.9 M | $ 2.3 | -3.0 % | $ 30.3 K | ||
|
Bellicum Pharmaceuticals
BLCM
|
3.77 M | - | -9.72 % | $ 5.89 M | ||
|
Berkeley Lights
BLI
|
84 M | - | -7.31 % | $ 87 M | ||
|
Advaxis
ADXS
|
7.89 M | - | -9.65 % | $ 45.9 M | ||
|
Завод ДИОД
DIOD
|
195 M | - | - | - | ||
|
Фармсинтез
LIFE
|
1.04 B | - | - | - | ||
|
BioLineRx Ltd.
BLRX
|
25.4 M | $ 3.17 | -1.86 % | $ 908 M | ||
|
bluebird bio
BLUE
|
425 M | - | - | $ 546 M |